Literature DB >> 19377303

Prohibitin physically interacts with MCM proteins and inhibits mammalian DNA replication.

Wasia Rizwani1, Mark Alexandrow, Srikumar Chellappan.   

Abstract

Prohibitin, a tumor suppressor protein, has been shown to repress E2F-mediated transcription and arrest cell cycle progression. while prohibitin has been proposed to regulate cell cycle progression by repressing transcriptional targets of E2F1, it is not clear whether other mechanisms are also involved in mediating the growth arrest. Here we demonstrate that prohibitin can function as a potent inhibitor of DNA replication by interacting with members of Minichromosome maintenance complex of proteins (MCM2-7). The data presented here indicates that prohibitin can physically interact with MCM2, MCM5 and MCM7 in in vitro GST binding assays as well as in MCF-7 cells as seen by immunoprecipitation-western blot experiments. The association was cell cycle dependent, and more pronounced 4-8 hours after serum stimulation of quiescent cells. Prohibitin associated more robustly with MCM2 and MCM5 compared to MCM7, suggesting that prohibitin mainly interacts with the regulatory subunits of the MCM complex. Confirming these results, prohibitin was found to co-localize with MCM2, MCM5 and MCM7 in MCF-7 cells, as seen by double immunofluorescence experiments. Further, Prohibitin strongly inhibited DNA replication in an in vitro replication assay. These results strongly suggest that prohibitin effectively represses replication by interacting with the components of mammalian replication machinery and this might contribute to the growth regulatory properties of prohibitin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19377303      PMCID: PMC2805263          DOI: 10.4161/cc.8.10.8578

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  62 in total

1.  Prohibitin facilitates cellular senescence by recruiting specific corepressors to inhibit E2F target genes.

Authors:  Shipra Rastogi; Bharat Joshi; Piyali Dasgupta; Mark Morris; Kenneth Wright; Srikumar Chellappan
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

Review 2.  ORC function in late G1: maintaining the license for DNA replication.

Authors:  Lance F Da-Silva; Bernard P Duncker
Journal:  Cell Cycle       Date:  2007-01-26       Impact factor: 4.534

3.  DNA replication in protein extracts from human cells requires ORC and Mcm proteins.

Authors:  Jens Baltin; Sandra Leist; Florian Odronitz; Hans-Peter Wollscheid; Martina Baack; Thomas Kapitza; Daniel Schaarschmidt; Rolf Knippers
Journal:  J Biol Chem       Date:  2006-03-13       Impact factor: 5.157

4.  Control of the Cdc6 replication licensing factor in metazoa: the role of nuclear export and the CUL4 ubiquitin ligase.

Authors:  Jihyun Kim; Edward T Kipreos
Journal:  Cell Cycle       Date:  2007-11-03       Impact factor: 4.534

5.  Prohibitins regulate membrane protein degradation by the m-AAA protease in mitochondria.

Authors:  G Steglich; W Neupert; T Langer
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

6.  Distinct action of the retinoblastoma pathway on the DNA replication machinery defines specific roles for cyclin-dependent kinase complexes in prereplication complex assembly and S-phase progression.

Authors:  Wesley A Braden; Jon M Lenihan; Zhengdao Lan; K Scott Luce; William Zagorski; Emily Bosco; Michael F Reed; Jeanette G Cook; Erik S Knudsen
Journal:  Mol Cell Biol       Date:  2006-08-14       Impact factor: 4.272

7.  Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function.

Authors:  S Wang; N Nath; M Adlam; S Chellappan
Journal:  Oncogene       Date:  1999-06-10       Impact factor: 9.867

8.  RB loss promotes aberrant ploidy by deregulating levels and activity of DNA replication factors.

Authors:  Seetha V Srinivasan; Christopher N Mayhew; Sandy Schwemberger; William Zagorski; Erik S Knudsen
Journal:  J Biol Chem       Date:  2007-06-06       Impact factor: 5.157

Review 9.  Preventing re-replication of chromosomal DNA.

Authors:  J Julian Blow; Anindya Dutta
Journal:  Nat Rev Mol Cell Biol       Date:  2005-06       Impact factor: 94.444

10.  The N-terminal domain of the Drosophila retinoblastoma protein Rbf1 interacts with ORC and associates with chromatin in an E2F independent manner.

Authors:  Joseph Ahlander; Xiao-Bo Chen; Giovanni Bosco
Journal:  PLoS One       Date:  2008-07-30       Impact factor: 3.240

View more
  19 in total

1.  Relationships between deficits in tissue mass and transcriptional programs after partial hepatectomy in mice.

Authors:  Jiangning Li; Jean S Campbell; Claudia Mitchell; Ryan S McMahan; Xuesong Yu; Kimberly J Riehle; Roger E Bumgarner; Nelson Fausto
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

2.  Prohibitin Shuttles Between Mitochondria and the Nucleus to Control Genome Stability During the Cell Cycle.

Authors:  Yunqing Yu
Journal:  Plant Physiol       Date:  2019-04       Impact factor: 8.340

3.  Nuclear Prohibitin3 Maintains Genome Integrity and Cell Proliferation in the Root Meristem through Minichromosome Maintenance 2.

Authors:  Ruihua Huang; Si Shu; Mengling Liu; Chao Wang; Bei Jiang; Jieming Jiang; Chengwei Yang; Shengchun Zhang
Journal:  Plant Physiol       Date:  2019-01-23       Impact factor: 8.340

4.  Identification of prohibitin 1 as a potential prognostic biomarker in human pancreatic carcinoma using modified aqueous two-phase partition system combined with 2D-MALDI-TOF-TOF-MS/MS.

Authors:  Ning Zhong; Yazhou Cui; Xiaoyan Zhou; Tianliang Li; Jinxiang Han
Journal:  Tumour Biol       Date:  2014-10-25

5.  Adriamycin resistance-associated prohibitin gene inhibits proliferation of human osteosarcoma MG63 cells by interacting with oncogenes and tumor suppressor genes.

Authors:  Min-Dong Du; Kai-Yi He; Gang Qin; Jin Chen; Jin-Yi Li
Journal:  Oncol Lett       Date:  2016-07-14       Impact factor: 2.967

6.  Identification of rep-associated factors in herpes simplex virus type 1-induced adeno-associated virus type 2 replication compartments.

Authors:  Armel Nicolas; Nathalie Alazard-Dany; Coline Biollay; Loredana Arata; Nelly Jolinon; Lauriane Kuhn; Myriam Ferro; Sandra K Weller; Alberto L Epstein; Anna Salvetti; Anna Greco
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

Review 7.  Prohibitin ligands: a growing armamentarium to tackle cancers, osteoporosis, inflammatory, cardiac and neurological diseases.

Authors:  Dong Wang; Redouane Tabti; Sabria Elderwish; Hussein Abou-Hamdan; Amel Djehal; Peng Yu; Hajime Yurugi; Krishnaraj Rajalingam; Canan G Nebigil; Laurent Désaubry
Journal:  Cell Mol Life Sci       Date:  2020-02-15       Impact factor: 9.261

8.  Dose- and time-dependent expression patterns of zebrafish orthologs of selected E2F target genes in response to serum starvation/replenishment.

Authors:  Ceren Sucularli; Serif Senturk; Mehmet Ozturk; Ozlen Konu
Journal:  Mol Biol Rep       Date:  2010-11-30       Impact factor: 2.316

Review 9.  The role and therapeutic potential of prohibitin in disease.

Authors:  Arianne L Theiss; Shanthi V Sitaraman
Journal:  Biochim Biophys Acta       Date:  2011-02-04

10.  Involvement of prohibitin upregulation in abrin-triggered apoptosis.

Authors:  Yu-Huei Liu; Konan Peck; Jung-Yaw Lin
Journal:  Evid Based Complement Alternat Med       Date:  2011-09-25       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.